Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perclose Alone vs Perclose + Statseal Following Transfemoral Catheterization
NCT05468957Withdrawn
- Sponsor
- University of California, Los Angeles
- Start
- Aug 2022
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by University of California, Los Angeles. Primary endpoint: Time to Ambulation at 24 hours. Planned start Aug 2022; status: withdrawn.
Beyond the preview
Go deeper on NCT05468957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05468957.